|
|
41
|
|
|
1171V
|
|
|
ALDOMET 250MG TAB (ASG) METHYLDOPA
|
|
|
METHYLDOPA
|
|
|
ALDOMET
|
|
|
30'S
|
|
|
A
|
|
|
11.63
|
|
|
0.3878
|
|
|
250MG
|
|
|
TAB
|
|
|
180
|
|
|
BOX
|
|
|
ASG
|
|
|
ASPEN OSD (GLOBAL)
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
B
|
|
|
Anti-Hypertensive
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
1 TD
|
|
|
3
|
|
|
N
|
|
|
240816
|
|
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|